Amgen posted strong earnings beat and has an attractive dividend, and technical chart forecasting positive future performance ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

We recently compiled a list of the 7 Cheap Quarterly Dividend Stocks to Invest in. In this article, we are going to take a ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.CTQLEHs_.js ...

Amgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of ...

Drugmakers have raised the list prices of more than 800 prescription drugs — ranging from blood pressure medications to cancer treatments — by a median of 4% at the start of this year, The Wall Street ...

The next drug Amgen brought to market in 1991 was Neupogen ... and became even large enough to register on the list of top pharma companies, rating as the 15th largest in the world in 2008.

Every year, a health care think tank called the Lown Institute ranks the 10 worst examples of "profiteering and dysfunction" ...

Amgen’s next-generation cholesterol drug has shown it can reverse the build ... to pay for the high-priced medicines, which have a list price of $14,000. But if the treatments can show ...

The fourth-quarter 2024 earnings cycle is here, with quite a few healthcare companies having reported results. Early reports ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.